Generic Name: Ixekizumab
Brand Name: Taltz
Manufacturer: Eli Lilly Canada Inc.
Therapeutic Area: Psoriasis, moderate to severe plaque
Indications: Psoriasis, moderate to severe plaque
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: October 25, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions